Medpace Holdings, Inc. (MEDP): Price and Financial Metrics

Medpace Holdings, Inc. (MEDP)

Today's Latest Price: $124.84 USD

2.82 (2.31%)

Updated Aug 7 12:00am

Add MEDP to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 68 in Medical - Services

See all "A" rated Strong Buy stocks

MEDP Stock Summary

  • With a one year PEG ratio of 383.29, Medpace Holdings Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 90.48% of US stocks.
  • MEDP's went public 3.99 years ago, making it older than merely 14.02% of listed US stocks we're tracking.
  • With a year-over-year growth in debt of 162.93%, Medpace Holdings Inc's debt growth rate surpasses 91.44% of about US stocks.
  • Stocks that are quantitatively similar to MEDP, based on their financial statements, market capitalization, and price volatility, are TTGT, CBPO, EVR, IMAX, and MC.
  • MEDP's SEC filings can be seen here. And to visit Medpace Holdings Inc's official web site, go to
MEDP Daily Price Range
MEDP 52-Week Price Range

MEDP Stock Price Chart Technical Analysis Charts

MEDP Price/Volume Stats

Current price $124.84 52-week high $144.49
Prev. close $122.02 52-week low $58.72
Day low $121.37 Volume 225,800
Day high $125.00 Avg. volume 316,936
50-day MA $99.86 Dividend yield N/A
200-day MA $86.93 Market Cap 4.42B

Medpace Holdings, Inc. (MEDP) Company Bio

Medpace, Inc. operates as a contract research organization that provides research based drug and medical device development services. The company was founded in 1992 and is based in Cincinnati, Ohio.

MEDP Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$124.84$120.68 -4%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Medpace Holdings Inc. To summarize, we found that Medpace Holdings Inc ranked in the 47th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Medpace Holdings Inc ended up being:

  • The company's balance sheet shows it gets 98% of its capital from equity, and 2% of its capital from debt. Notably, its equity weight is greater than 82.27% of US equities in the Healthcare sector yielding a positive free cash flow.
  • The business' balance sheet reveals debt to be 2% of the company's capital (with equity being the remaining amount). Approximately merely 9.49% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
  • Medpace Holdings Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -271.12. This coverage rate is greater than that of merely 0.74% of stocks we're observing for the purpose of forecasting via discounted cash flows.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

DXCM, HRC, STE, AMGN, and EDAP can be thought of as valuation peers to MEDP, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.

MEDP Latest News Stream

Event/Time News Detail
Loading, please wait...

MEDP Latest Social Stream

Loading social stream, please wait...

View Full MEDP Social Stream

Latest MEDP News From Around the Web

Below are the latest news stories about Medpace Holdings Inc that investors may wish to consider to help them evaluate MEDP as an investment opportunity.

Medpace Holdings, Inc. Just Beat EPS By 58%: Here's What Analysts Think Will Happen Next

As you might know, Medpace Holdings, Inc. (NASDAQ:MEDP) just kicked off its latest second-quarter results with some...

Yahoo | July 30, 2020

Medpace Holdings, Inc. (NASDAQ:MEDP) Not Flying Under The Radar

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may...

Yahoo | July 29, 2020

Medpace cheers Q2 revenue & EPS beat

Medpace ([[MEDP]] +8.1%) reported Q2 revenue of $205M, ahead of consensus by $23.8M, with a backlog conversion rate of 15.8%.Net income of $24.1M or $0.64/share, beating consensus by $0.28.Net new business awards stood at $254.1M, 9% Y/Y drop leading to net book-to-bill ratio of 1.24x.EBITDA was down 12.9% to $35M.As of...

Seeking Alpha | July 28, 2020

Medspace Holdings (MEDP) Investor Presentation - Slideshow

The following slide deck was published by Medpace Holdings, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | July 28, 2020

Is a Surprise Coming for Medpace (MEDP) This Earnings Season?

Medpace (MEDP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Yahoo | July 24, 2020

Read More 'MEDP' Stories Here

MEDP Price Returns

1-mo 27.15%
3-mo 45.21%
6-mo 28.83%
1-year 58.69%
3-year 304.14%
5-year N/A
YTD 48.51%
2019 58.81%
2018 45.97%
2017 0.53%
2016 N/A
2015 N/A

Continue Researching MEDP

Here are a few links from around the web to help you further your research on Medpace Holdings Inc's stock as an investment opportunity:

Medpace Holdings Inc (MEDP) Stock Price | Nasdaq
Medpace Holdings Inc (MEDP) Stock Quote, History and News - Yahoo Finance
Medpace Holdings Inc (MEDP) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9088 seconds.